
Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.
For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote monitoring initiatives, can improve enrollment.






